{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:17:41Z","timestamp":1778919461748,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007099","name":"San Diego State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pbb.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T19:04:16Z","timestamp":1445281456000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice"],"prefix":"10.1016","volume":"139","author":[{"given":"Monzurul Amin","family":"Roni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.10.006_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2008.08.016","article-title":"Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests","volume":"197","author":"Andreasen","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2015.10.006_bb0010","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/bi100536t","article-title":"Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors","volume":"49","author":"Arias","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbb.2015.10.006_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-009-1583-7","article-title":"Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice","volume":"206","author":"Bourin","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.10.006_bb0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.10.006_bb0025","series-title":"Clinical Pharmacology and Therapeutics of Antidepressants. Pharmacotherapy of depression","first-page":"33","author":"Ciraulo","year":"2011"},{"key":"10.1016\/j.pbb.2015.10.006_bb0030","first-page":"68","article-title":"Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists","volume":"152","author":"Collins","year":"1990","journal-title":"CIBA Found. Symp."},{"key":"10.1016\/j.pbb.2015.10.006_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(24)36807-7","article-title":"Pharmacology of lobeline, a nicotinic receptor ligand","volume":"282","author":"Damaj","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.10.006_bb0045","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-2952(01)00899-1","article-title":"A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse","volume":"63","author":"Dwoskin","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1471-4159.1998.70020663.x","article-title":"Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture","volume":"70","author":"Gallardo","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2015.10.006_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2015.10.006_bb0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic\u2013adrenergic hypothesis of mania and depression","volume":"300","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2015.10.006_bb0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pbb.2015.10.006_bb0085","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1471-4159.2000.0752409.x","article-title":"Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release","volume":"75","author":"Kenny","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2015.10.006_bb0090","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0028-3908(96)00115-3","article-title":"Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H]5-HT from rat hippocampal slices","volume":"35","author":"Lendvai","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(95)00573-4","article-title":"Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study","volume":"286","author":"Malagi\u00e9","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0100","series-title":"Psychopharmacology: Drugs, the Brain, and Behavior","first-page":"26","author":"Meyer","year":"2005"},{"key":"10.1016\/j.pbb.2015.10.006_bb0105","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0028-3908(00)00140-4","article-title":"Lobeline inhibits nicotine-evoked [3H] dopamine overflow from rat striatal slices and nicotine-evoked 86Rb+ efflux from thalamic synaptosomes","volume":"39","author":"Miller","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/jpet.302.2.687","article-title":"Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors","volume":"302","author":"Miller","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.10.006_bb0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0893-133X(02)00301-9","article-title":"Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex","volume":"27","author":"Page","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/mol.54.6.1132","article-title":"Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity","volume":"54","author":"Parker","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0125","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.bjp.0705359","article-title":"Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram","volume":"139","author":"Popik","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2015.10.006_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008877-200502000-00007","article-title":"Effects of acute bupropion administration on locomotor activity in adolescent and adult mice","volume":"16","author":"Redolat","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.006_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/abio.1994.1271","article-title":"Measurement of liver microsomal cytochrome p450 (CYP2D6) activity using [O-methyl-14C]dextromethorphan","volume":"219","author":"Rodrigues","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pbb.2015.10.006_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2011.09.035","article-title":"Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice","volume":"504","author":"Roni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2015.10.006_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pnpbp.2012.11.011","article-title":"Neuronal nicotinic receptor antagonist lobeline has antidepressant-like properties in mice","volume":"41","author":"Roni","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.10.006_bb0155","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00213-014-3472-y","article-title":"The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice","volume":"231","author":"Roni","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.physbeh.2012.06.023","article-title":"Translating laboratory discovery to the clinic: from nicotine and mecamylamine to tourettes, depression, and beyond","volume":"107","author":"Sanberg","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2015.10.006_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.10.006_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0175","doi-asserted-by":"crossref","unstructured":"Tallarida, R.J., Stone, D.J. Jr., Raffa, R.B., 1997. Efficient designs for studying synergistic drug combinations. Life Sci. 61, PL 417-425.","DOI":"10.1016\/S0024-3205(97)01030-8"},{"key":"10.1016\/j.pbb.2015.10.006_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.1998.71010258.x","article-title":"Lobeline displaces [3H] dihydrotetrabenazine binding and releases [3H] dopamine from rat striatal synaptic vesicles: comparison with d amphetamine","volume":"71","author":"Teng","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2015.10.006_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuropharm.2013.04.027","article-title":"Therapeutic doses of antidepressants are projected not to inhibit human \u03b14\u03b22 nicotinic acetylcholine receptors","volume":"72","author":"Weber","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2015.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0090-9556(24)14936-7","article-title":"Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes","volume":"27","author":"Wienkers","year":"1999","journal-title":"Drug Metab. Dispos."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T02:24:04Z","timestamp":1748658244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715300782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"alternative-id":["S0091305715300782"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}